• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,532.96 325.72
( 0.44%)
Global Indices
Nasdaq
46,043.89 -202.27
(-0.44%)
Dow Jones
6,628.50 -17.20
(-0.26%)
Hang Seng
53,297.18 -1,942.22
(-3.52%)
Nikkei 225
10,057.93 -247.36
(-2.40%)
Forex
USD-INR
92.72 0.33
(0.36%)
EUR-INR
106.76 0.38
(0.35%)
GBP-INR
123.58 0.43
(0.35%)
JPY-INR
0.58 0.00
(0.28%)

EQUITY - MARKET SCREENER

ANG Lifesciences India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540694
INE236W01016
49.9768362
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
28.83
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

lodha developers pvt ltd
Board of CCL Products (India) recommends interim dividend
Feb 05,2026
CCL Products (India) announced that the Board of Directors of the Company at its meeting held on 4 February 2026, inter alia, have recommended the interim dividend of Rs 2.75 per equity Share (i.e. 137.5%) , subject to the approval of the shareholders.